Literature DB >> 18606839

Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.

Carlo McCalla1, Davida S Smyth, D Ashley Robinson, Judith Steenbergen, Steven A Luperchio, Pamela A Moise, Vance G Fowler, George Sakoulas.   

Abstract

In a recent landmark trial of bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) isolates, vancomycin MICs were >or=1 microg/ml for only 16% of the isolates, and accessory gene regulator (agr) function as measured by delta-hemolysin activity was absent or reduced in only 28.1% of the isolates. This clinical study did not capture a population of MRSA isolates predictive of vancomycin treatment failure.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18606839      PMCID： PMC2533503          DOI： 10.1128/AAC.00357-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Authors:  Dag Harmsen; Heike Claus; Wolfgang Witte; Jörg Rothgänger; Hermann Claus; Doris Turnwald; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis.

Authors:  Philippe Gilot; Gérard Lina; Thierry Cochard; Bernard Poutrel
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus.

Authors:  T Ito; Y Katayama; K Asada; N Mori; K Tsutsumimoto; C Tiensasitorn; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.

Authors:  George Sakoulas; George M Eliopoulos; Robert C Moellering; Christine Wennersten; Lata Venkataraman; Richard P Novick; Howard S Gold
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents.

Authors:  Brian T Tsuji; Michael J Rybak; Chrissy M Cheung; Muhammad Amjad; Glenn W Kaatz
Journal:  Diagn Microbiol Infect Dis       Date:  2007-02-14       Impact factor: 2.803

6.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

7.  spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation.

Authors:  Larry Koreen; Srinivas V Ramaswamy; Edward A Graviss; Steven Naidich; James M Musser; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

8.  Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus.

Authors:  D Ashley Robinson; Mark C Enright
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  George Sakoulas; Pamela A Moise-Broder; Jerome Schentag; Alan Forrest; Robert C Moellering; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections.

Authors:  Cynthia L Maree; Robert S Daum; Susan Boyle-Vavra; Kelli Matayoshi; Loren G Miller
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883
View more
  12 in total

1.  Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.

Authors:  Kati Seidl; Arnold S Bayer; Vance G Fowler; James A McKinnell; Wessam Abdel Hady; George Sakoulas; Michael R Yeaman; Yan Q Xiong
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

2.  Early agr activation correlates with vancomycin treatment failure in multi-clonotype MRSA endovascular infections.

Authors:  Wessam Abdelhady; Liang Chen; Arnold S Bayer; Kati Seidl; Michael R Yeaman; Barry N Kreiswirth; Yan Q Xiong
Journal:  J Antimicrob Chemother       Date:  2015-01-05       Impact factor: 5.790

3.  Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycin.

Authors:  Kerry J Welsh; Kimberly A Skrobarcek; April N Abbott; Cole T Lewis; Mark C Kruzel; Evan M Lewis; Jeanelle M Gardiner; John F Mohr; Lisa Y Armitige; Audrey Wanger
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

4.  Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  Kati Seidl; Liang Chen; Arnold S Bayer; Wessam Abdel Hady; Barry N Kreiswirth; Yan Q Xiong
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

5.  Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach.

Authors:  Adrien Fischer; Soo-Jin Yang; Arnold S Bayer; Ali R Vaezzadeh; Sébastien Herzig; Ludwig Stenz; Myriam Girard; George Sakoulas; Alexander Scherl; Michael R Yeaman; Richard A Proctor; Jacques Schrenzel; Patrice François
Journal:  J Antimicrob Chemother       Date:  2011-05-28       Impact factor: 5.790

6.  In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  Kati Seidl; Arnold S Bayer; James A McKinnell; Steven Ellison; Scott G Filler; Yan Q Xiong
Journal:  Cell Microbiol       Date:  2011-07-21       Impact factor: 3.715

7.  Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.

Authors:  Pamela A Moise; Alan Forrest; Arnold S Bayer; Yan Q Xiong; Michael R Yeaman; George Sakoulas
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

8.  Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients.

Authors:  Nagendra N Mishra; Arnold S Bayer; Pamela A Moise; Michael R Yeaman; George Sakoulas
Journal:  J Infect Dis       Date:  2012-08-16       Impact factor: 5.226

9.  Endovascular infections caused by methicillin-resistant Staphylococcus aureus are linked to clonal complex-specific alterations in binding and invasion domains of fibronectin-binding protein A as well as the occurrence of fnbB.

Authors:  Yan Q Xiong; Batu K Sharma-Kuinkel; Nadia N Casillas-Ituarte; Vance G Fowler; Thomas Rude; Alex C DiBartola; Roberto D Lins; Wessam Abdel-Hady; Steven K Lower; Arnold S Bayer
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

10.  Variations in amount of TSST-1 produced by clinical methicillin resistant Staphylococcus aureus (MRSA) isolates and allelic variation in accessory gene regulator (agr) locus.

Authors:  Miki Nagao; Akira Okamoto; Keiko Yamada; Tadao Hasegawa; Yoshinori Hasegawa; Michio Ohta
Journal:  BMC Microbiol       Date:  2009-03-10       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.